Rothschild Capital Partners LLC Has $8.73 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Rothschild Capital Partners LLC boosted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 7.2% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 17,266 shares of the healthcare conglomerate’s stock after acquiring an additional 1,160 shares during the period. UnitedHealth Group accounts for 2.1% of Rothschild Capital Partners LLC’s portfolio, making the stock its 17th largest position. Rothschild Capital Partners LLC’s holdings in UnitedHealth Group were worth $8,734,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. Norges Bank acquired a new position in UnitedHealth Group during the fourth quarter valued at approximately $6,375,744,000. Raymond James Financial Inc. bought a new stake in shares of UnitedHealth Group in the 4th quarter valued at $1,914,740,000. Amundi lifted its holdings in UnitedHealth Group by 97.2% during the fourth quarter. Amundi now owns 6,069,100 shares of the healthcare conglomerate’s stock worth $3,183,132,000 after acquiring an additional 2,991,470 shares in the last quarter. Proficio Capital Partners LLC raised its position in shares of UnitedHealth Group by 76,830.4% during the fourth quarter. Proficio Capital Partners LLC now owns 1,888,641 shares of the healthcare conglomerate’s stock worth $955,388,000 after purchasing an additional 1,886,186 shares during the period. Finally, Capital International Investors lifted its stake in UnitedHealth Group by 6.2% in the fourth quarter. Capital International Investors now owns 15,616,007 shares of the healthcare conglomerate’s stock valued at $7,899,905,000 after buying an additional 906,365 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts recently weighed in on the stock. Argus lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Monday. Raymond James reissued a “strong-buy” rating and issued a $540.00 target price (down previously from $635.00) on shares of UnitedHealth Group in a research report on Monday. Royal Bank of Canada decreased their target price on shares of UnitedHealth Group from $655.00 to $525.00 and set an “outperform” rating for the company in a research report on Wednesday. HSBC restated a “hold” rating and set a $490.00 price objective on shares of UnitedHealth Group in a research note on Tuesday. Finally, Oppenheimer dropped their target price on UnitedHealth Group from $640.00 to $600.00 and set an “outperform” rating on the stock in a report on Monday. Three research analysts have rated the stock with a hold rating, nineteen have given a buy rating and three have assigned a strong buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Buy” and a consensus target price of $603.05.

UnitedHealth Group Price Performance

UnitedHealth Group stock opened at $424.70 on Friday. The firm has a market cap of $388.48 billion, a PE ratio of 27.40, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a one year low of $417.12 and a one year high of $630.73. The stock’s fifty day moving average price is $504.95 and its two-hundred day moving average price is $536.14.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). The business had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same quarter in the prior year, the company earned $6.91 earnings per share. As a group, research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were paid a $2.10 dividend. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 annualized dividend and a dividend yield of 1.98%. UnitedHealth Group’s payout ratio is 35.18%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.